St. Jude says report by short sellers 'false and misleading'
- Stocks decline as interest rate uncertainty, earnings weigh
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- US dollar weakens as market consolidates gains, but uptrend intact
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Stocks have priced in much of the 2024 optimism - Wells Fargo
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
St. Jude Medical (STJ) Shares Move Higher on Resumption
August 26, 2016 3:46 PM EDTSt. Jude Medical (NYSE: STJ) shares resume trading. The stock is moving up after being negative most of Friday's session.
... MoreAbbott (ABT) on Watch as St. Jude (STJ) Rebukes Allegations from Short Seller
August 26, 2016 3:45 PM EDTAbbott (NYSE: ABT) shares are ticking slightly higher late Friday as St. Jude Medical (NYSE: STJ) said it refutes claims made by short-seller Muddy Waters. The stock is up modestly.
Abbott and St. Jude entered at $31 billion merger agreement earlier this year.
... More